High-sensitivity C-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: A substudy from the CHARISMA trial

M. Weber, D.L. Bhatt, D.M. Brennan, Graeme Hankey, S.R. Steinhubl, S.C. Johnston, G. Montalescot, K.-H. Mak, K.A.A. Fox, D.J. Easton, E.J. Topol, C.W. Hamm

Research output: Contribution to journalArticle

12 Citations (Scopus)
Original languageEnglish
Pages (from-to)626-631
Publication statusPublished - 2011

Cite this